Glenview Trust Co Purchases New Position in Corteva, Inc. $CTVA

Glenview Trust Co acquired a new stake in shares of Corteva, Inc. (NYSE:CTVA) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 10,598 shares of the company’s stock, valued at approximately $898,000.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. William B. Walkup & Associates Inc. lifted its position in Corteva by 2.9% during the first quarter. William B. Walkup & Associates Inc. now owns 4,457 shares of the company’s stock valued at $373,000 after acquiring an additional 126 shares during the last quarter. Wilkerson Advisory Group LLC grew its stake in Corteva by 6.7% during the 1st quarter. Wilkerson Advisory Group LLC now owns 2,112 shares of the company’s stock worth $177,000 after buying an additional 133 shares during the last quarter. AdvisorNet Financial Inc raised its stake in Corteva by 2.4% in the first quarter. AdvisorNet Financial Inc now owns 5,694 shares of the company’s stock valued at $477,000 after buying an additional 135 shares during the last quarter. First Horizon Corp boosted its holdings in Corteva by 9.2% in the first quarter. First Horizon Corp now owns 1,600 shares of the company’s stock worth $134,000 after acquiring an additional 135 shares in the last quarter. Finally, Aviance Capital Partners LLC increased its holdings in shares of Corteva by 1.3% during the first quarter. Aviance Capital Partners LLC now owns 11,008 shares of the company’s stock valued at $922,000 after acquiring an additional 137 shares in the last quarter. Institutional investors own 81.54% of the company’s stock.

Corteva Price Performance

Shares of NYSE CTVA opened at $84.00 on Friday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52. The firm has a fifty day moving average of $82.69 and a 200 day moving average of $80.54. The firm has a market cap of $56.04 billion, a PE ratio of 55.63, a PEG ratio of 2.53 and a beta of 0.57. Corteva, Inc. has a one year low of $60.53 and a one year high of $90.97.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.24 by $0.06. The business had revenue of $6.38 billion for the quarter, compared to the consensus estimate of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The company’s revenue was down 1.2% compared to the same quarter last year. During the same period last year, the firm posted $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, research analysts predict that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be paid a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Tuesday, September 1st. Corteva’s dividend payout ratio (DPR) is currently 47.68%.

Wall Street Analyst Weigh In

CTVA has been the subject of a number of research analyst reports. Jefferies Financial Group raised their price target on shares of Corteva from $95.00 to $97.00 in a report on Thursday, May 7th. Mizuho increased their price objective on Corteva from $96.00 to $97.00 and gave the company an “outperform” rating in a report on Tuesday, July 14th. Bank of America upped their target price on Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a research report on Monday, July 20th. Oppenheimer lifted their price objective on shares of Corteva from $89.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, July 23rd. Finally, Zacks Research cut shares of Corteva from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 11th. Fourteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $91.50.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.